Blanchette’s paper, titled “Use of Complexation Hydrogels for Oral Administration of Chemotherapeutic Agents,” discussed the development of a system to administer cancer drugs orally.
“We hope that successful development of this technology will lead to improved quality of life for chemotherapy patients as well as provide new treatment options for physicians,” he said.
Blanchette will present his work at the annual meeting of the Controlled Release Society in Glasgow, Scotland. His research is supervised by Dr. Nicholas Peppas.
The Controlled Release Society is a multi-disciplinary organization dedicated to the science and technology of controlled release, the field of study concerned with the biological effect rate of therapeutic drugs in human and animal health.
Email this article to a friend
About UT's Cockrell School of Engineering:
The University of Texas at Austin's Cockrell School of Engineering ranks among the top six public engineering schools in the United States. With the nation's fourth highest number of faculty elected members of the National Academy of Engineering, the School's more than 7,000 students gain exposure to the nation's finest engineering practitioners. Appropriately, the School's logo, an embellished checkmark used by the first UT engineering dean to denote high quality student work, is the nation's oldest quality symbol. The School maintains a Web site at http://www.engr.utexas.edu